Pardeep Nijhawan, Chief Executive Officer, 10% Owner at Edesa Biotech, Inc. (EDSA), bought 2,000 shares at $3.26 ($7K) on 2022-03-17, disclosed to the SEC on 2022-03-18.
Open-market purchase of $7k EDSA by Chief Executive Officer, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.25 | 397 | $1K | 19.8% |
| 2 | $3.26 | 1,603 | $5K | 80.2% |
| Total | $3.26 avg | 2,000 | $7K | 100% |
| Filing → |
| EDSA | BUY | 2026-03-05 | $43K | — | Filing → |
| EDSA | BUY | 2026-03-04 | $36K | — | Filing → |
| EDSA | BUY | 2026-03-03 | $6K | — | Filing → |